Cargando…
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score
Data presented in this article are supplementary material to our article entitled “Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an “FCS Score” (Moulin et al., 2018, in press). The data describe the genotypes of p...
Autores principales: | Moulin, Philippe, Dufour, Robert, Averna, Maurizio, Arca, Marcello, Cefalù, Angelo B., Noto, Davide, D’Erasmo, Laura, Di Costanzo, Alessia, Marçais, Christophe, Walther, Luis Antonio Alvarez-Sala, Banach, Maciej, Borén, Jan, Cramb, Robert, Gouni-Berthold, Ioanna, Hughes, Elizabeth, Johnson, Colin, Pintó, Xavier, Reiner, Željko, van Lennep, Jeanine Roeters, Soran, Handrean, Stefanutti, Claudia, Stroes, Erik, Bruckert, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231039/ https://www.ncbi.nlm.nih.gov/pubmed/30456254 http://dx.doi.org/10.1016/j.dib.2018.10.125 |
Ejemplares similares
-
Olanzapine-induced multifactorial chylomicronaemia syndrome: a rare but important complication
por: Cooper, Bridget, et al.
Publicado: (2023) -
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options
por: Bashir, Bilal, et al.
Publicado: (2023) -
APOC3 Interference for Familial Chylomicronaemia Syndrome
por: Hegele, Robert A
Publicado: (2022) -
Clinical heterogeneity in monogenic chylomicronaemia
por: Heidemann, Britt E, et al.
Publicado: (2022) -
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)